Adiuvo Investment SA (ADV) - Total Liabilities

Latest as of March 2026: zł48.83 Million PLN ≈ $13.44 Million USD

Based on the latest financial reports, Adiuvo Investment SA (ADV) has total liabilities worth zł48.83 Million PLN (≈ $13.44 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore Adiuvo Investment SA (ADV) investment intensity to see how much of total assets are deployed in long-term investments.

Adiuvo Investment SA - Total Liabilities Trend (2013–2025)

This chart illustrates how Adiuvo Investment SA's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see balance sheet size of Adiuvo Investment SA.

Adiuvo Investment SA Competitors by Total Liabilities

The table below lists competitors of Adiuvo Investment SA ranked by their total liabilities.

Company Country Total Liabilities
Qlucore AB
ST:QCORE
Sweden Skr5.71 Million
Camerit AG
F:RTML
Germany €274.65K
Starbreeze AB (publ)
ST:STAR-A
Sweden Skr116.45 Million
Moab Minerals Ltd
AU:MOM
Australia AU$2.34 Million
AEW UK REIT Plc
LSE:AEWU
UK GBX67.82 Million
Quinsam Capital Corporation
F:0Q4
Germany €105.79K
CFI-Compagnie Foncière Internationale
PA:CFI
France €225.00K

Liability Composition Analysis (2013–2025)

This chart breaks down Adiuvo Investment SA's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See Adiuvo Investment SA (ADV) net asset quality to measure how much of total assets are equity-financed.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 0.06 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity -1.34 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 3.17 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Adiuvo Investment SA's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Adiuvo Investment SA (2013–2025)

The table below shows the annual total liabilities of Adiuvo Investment SA from 2013 to 2025.

Year Total Liabilities Change
2025-12-31 zł45.81 Million
≈ $12.61 Million
+29.65%
2024-12-31 zł35.34 Million
≈ $9.73 Million
-24.71%
2023-12-31 zł46.93 Million
≈ $12.92 Million
-15.55%
2022-12-31 zł55.58 Million
≈ $15.30 Million
+12.71%
2021-12-31 zł49.31 Million
≈ $13.57 Million
+17.32%
2020-12-31 zł42.03 Million
≈ $11.57 Million
+43.89%
2019-12-31 zł29.21 Million
≈ $8.04 Million
+1.57%
2018-12-31 zł28.76 Million
≈ $7.91 Million
+87.06%
2017-12-31 zł15.37 Million
≈ $4.23 Million
-25.90%
2016-12-31 zł20.75 Million
≈ $5.71 Million
-17.87%
2015-12-31 zł25.27 Million
≈ $6.95 Million
+20.79%
2014-12-31 zł20.92 Million
≈ $5.76 Million
+67.32%
2013-12-31 zł12.50 Million
≈ $3.44 Million
--

About Adiuvo Investment SA

WAR:ADV Poland Medical Devices
Market Cap
$2.02 Million
zł7.32 Million PLN
Market Cap Rank
#30038 Global
#348 in Poland
Share Price
zł0.56
Change (1 day)
+4.51%
52-Week Range
zł0.39 - zł0.84
All Time High
zł31.50
About

Adiuvo Investments S.A. is a venture capital firm specializing in incubation, seed, startup, early venture, and growth capital investments. The firm primarily invests in projects in the segment of medical devices, biomedical, life-science, digital health, technologies and nutraceuticals including functional food. It seeks to invest in Poland. It prefers to hold its investments from three up to fi… Read more